Answers are grounded in this paper and cite their sources.
As a prevalent skeletal disorder, osteoporosis is characterized by reduced bone mass, disrupted bone microarchitecture, and increased bone fragility. Excessive oxidative stress and mitochondrial dysfunction are key contributors to the pathogenesis of osteoporosis. While plantamajoside exhibits anti-inflammatory, antioxidant, and anti-apoptotic bioactivities, the mechanism underlying its preventive effect against osteoporosis remains unclear. This study aimed to explore whether plantamajoside produces protective effects against oxidative stress-mediated osteoporosis. An ovariectomized rat model of osteoporosis was constructed, and bone marrow mesenchymal stem cells were stimulated with hydrogen peroxide. Oxidative stress-related indicators and signaling pathways were assessed, together with bone phenotyping, cellular staining, Western blot analysis, and Nrf2 ubiquitination assays. Plantamajoside ameliorated ovariectomy-induced bone loss, recovered trabecular microarchitecture, suppressed excessive reactive oxygen species production and mitochondrial damage, and restored osteogenic differentiation capacity. It facilitated Nrf2 nuclear translocation by inhibiting Nrf2 ubiquitination. Plantamajoside alleviates osteoporosis by stabilizing the Nrf2 signaling pathway through reducing Nrf2 ubiquitination. These findings offer mechanistic evidence supporting the application of plantamajoside for the prevention and treatment of osteoporosis.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: